Literature DB >> 21501869

Hemophagocytic syndrome associated NK/T nasal type lymphoma presenting as hypereosinophilic syndrome: a case report and literature review.

Esperanza Romero Fernández, José Ramón Paño Pardo, Andrew Doyle, Miguel Canales Albendea, Ana Rodríguez de la Rúa.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21501869     DOI： 10.1016/j.leukres.2010.12.020

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  3 in total

1.  Trial of LVDP regimen (L-asparaginase, etoposide, dexamethasone, and cisplatin, followed by radiotherapy) as first-line treatment for newly diagnosed, stage III/IV extranodal natural killer/T cell lymphoma.

Authors:  Y Q Wang; Y Yang; H Y Zhuo; L Q Zou; Y Jiang; M Jiang
Journal:  Med Oncol       Date:  2015-01-09       Impact factor: 3.064

2.  Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes.

Authors:  Florence E Roufosse; Jean-Emmanuel Kahn; Gerald J Gleich; Lawrence B Schwartz; Anish D Singh; Lanny J Rosenwasser; Judah A Denburg; Johannes Ring; Marc E Rothenberg; Javed Sheikh; Ann E Haig; Stephen A Mallett; Deborah N Templeton; Hector G Ortega; Amy D Klion
Journal:  J Allergy Clin Immunol       Date:  2012-10-04       Impact factor: 10.793

3.  A Very Rare Case of Hypereosinophilic Syndrome Secondary to Natural Killer/T-Cell Lymphoma.

Authors:  Takanori Yamamoto; Atsushi Kamijo; Tadao Nakazawa; Kei Nakajima; Keita Kirito; Norio Komatsu; Keisuke Masuyama
Journal:  Case Rep Otolaryngol       Date:  2018-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.